The influence of azithromycin on the biofilm formation of pseudomonas aeruginosa in vitro

Chemotherapy

Volumn 42, Issue 3, 1996, Pages 186-191

  Ichimiya, Tomoku ^a   Takeoka, Kaori ^a   Hiramatsu, Kazufumi ^a   Hirai, Kazuhiro ^a   Yamasaki, Tohru ^a   Nasu, Masaru ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Alginic acid; Azithromycin; Biofilm; Glycocalyx

Indexed keywords

ALGINIC ACID; AZITHROMYCIN; MACROLIDE; POLYSACCHARIDE;

ARTICLE; BACTERIUM COLONY; BACTERIUM CULTURE; BIOFILM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY;

EID: 0029918621     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239440     Document Type: Article

References (17)

1. Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, Marrie TJ: Bacterial biofilms in nature and disease. Ann Rev Microbiol 1987;41:435-464.
2. Anwar H, Dasqupta M, Lam K, Costerton JW: Tobramycin resistance of mucoid Pseudomonas aeru-ginosa biofilm grown under ion limitation. J Antimicrob Chemother 1989;24:647-655.
3. Hoyle BD, Jass J, Costerton JW: The biofilm glycocalyx as a resistance factor. J Antimicrob Chemother 1990;26:1-6.
4. Anwar H, Biesen TV, Dasgupta M, Lam K, Costerton JW: Interaction of biofilm bacteria with antibiotics in a novel in vitro chcmostat system. Antimicrob Agents Chemother 1989;33:1824-1826.
5. Williams JD: Spectrum of activity of azithromycin. Eur J Clin Microbiol Infect Dis 1991;10:813-820.
6. Maskell JP, Sefton AM, Williams JD: Comparative in vitro activity of azithromycin against gram-positive cocci, Haemophilus influenzae and anaerobes. J Antimicrob Chemother 1990;25(suppl A): 19-24.
7. Foulds G, Shepard RM, Johnson RB: The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Cheinother 1990;25(suppl A):73-82.
8. Boldwin DR, Wise R, Andrews JM, Ashby JP, Honeybourne D: Azithromycin concentrations at the sites of pulmonary infection. Eur Respir J 1990;3:886-890.
9. Bradley DE: A function of Pseudomonas aeruginosa PAO polar pili: Twitching motility. Can J Microbiol 1984;26:146-154.
10. Terry JM, Pina SE, Matting SJ: Environmental conditions which influence mucoid conversion in Pseudomonas aeruginosa PAO 1. Infect Immun 1991;591:471-477.
11. Toyoda M, Yomota C, Ito Y, Ha-rada M: High performance liquid chromatographic method for the determination of sodium alginate in foods. J Food Hyg Soc Jpn 1985;26: 189-194.
12. Ichimiya T, Yamasaki T, Nasu M: In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation. J Antimicrob Chemother 1994;34:331-341.
13. Shetlar MR, Foster JV, Everett MR: Determination of serum polysaccharides by the tryptophan reaction. Proc Soc Exp Biol Med 1948:67: 125-130.
14. Dali L, Herndon B: Quantitative assay of glycocalyx produced by viri-dans group streptococci that cause endocarditis. J Clin Microbiol 1989; 27:2039-2041.
15. Costerton JW, Irvin RT, Cheng KJ: The bacterial glycocalyx in nature and disease. Annu Rev Microbiol 1981;35:299-324.
16. Buret A, Ward KH, Olson ME, Costerton JW: An in vivo model to study the pathobiology of infectious biofilms on biomaterial surfaces. J Biomed Mater Res 1991;25:865-874.
17. Lam J, Chan R, Lam K, Costerton JW: Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 1980;28: 546-556.